PTX 2.44% 4.2¢ prescient therapeutics limited

This may have been addressed previously, but given the...

  1. 19 Posts.
    lightbulb Created with Sketch. 2
    This may have been addressed previously, but given the languishing share price, how would a phase 2 trial be funded? PTX doesn't currently have the money for it. Surely the only option currently is a very dilutive capital raise. I can't see "Big Pharma" just throwing them a big pile of cash. Maybe if the trial is approved then the SP jumps and the dilution will be minimal. Thanks.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.